Georg Aue

2.1k total citations
52 papers, 1.0k citations indexed

About

Georg Aue is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Georg Aue has authored 52 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Hematology, 24 papers in Genetics and 18 papers in Pathology and Forensic Medicine. Recurrent topics in Georg Aue's work include Chronic Lymphocytic Leukemia Research (23 papers), Lymphoma Diagnosis and Treatment (17 papers) and Hematopoietic Stem Cell Transplantation (8 papers). Georg Aue is often cited by papers focused on Chronic Lymphocytic Leukemia Research (23 papers), Lymphoma Diagnosis and Treatment (17 papers) and Hematopoietic Stem Cell Transplantation (8 papers). Georg Aue collaborates with scholars based in United States, Denmark and Singapore. Georg Aue's co-authors include Adrian Wiestner, Xin Tian, Sarah E. M. Herman, Janet Valdez, Herbert S. Schwartz, Merlin G. Butler, Bethi Muralidhar, Susan Soto, Mohammed Farooqui and Gerald E. Marti and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Georg Aue

49 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Georg Aue United States 16 615 434 350 267 240 52 1.0k
Daniela Gottardi Italy 11 605 1.0× 379 0.9× 405 1.2× 120 0.4× 353 1.5× 19 1.0k
Simar Pal Singh Netherlands 9 387 0.6× 235 0.5× 337 1.0× 152 0.6× 226 0.9× 14 793
Andrea G.S. Buggins United Kingdom 19 474 0.8× 253 0.6× 628 1.8× 224 0.8× 332 1.4× 33 1.1k
John H. Proffitt United States 15 438 0.7× 447 1.0× 191 0.5× 188 0.7× 444 1.9× 17 1.1k
Siddha Kasar United States 14 522 0.8× 351 0.8× 342 1.0× 134 0.5× 448 1.9× 34 1.0k
Jeffrey S. Painter United States 16 344 0.6× 211 0.5× 635 1.8× 497 1.9× 474 2.0× 28 1.3k
Sophie Gazzo France 16 448 0.7× 453 1.0× 121 0.3× 136 0.5× 266 1.1× 32 856
Stefania Fiorcari Italy 17 492 0.8× 269 0.6× 300 0.9× 176 0.7× 272 1.1× 33 800
Maria Ciccone Italy 17 324 0.5× 173 0.4× 259 0.7× 211 0.8× 363 1.5× 45 818
Bryan Ciccarelli United States 13 320 0.5× 276 0.6× 302 0.9× 316 1.2× 530 2.2× 34 1.1k

Countries citing papers authored by Georg Aue

Since Specialization
Citations

This map shows the geographic impact of Georg Aue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georg Aue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georg Aue more than expected).

Fields of papers citing papers by Georg Aue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Georg Aue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georg Aue. The network helps show where Georg Aue may publish in the future.

Co-authorship network of co-authors of Georg Aue

This figure shows the co-authorship network connecting the top 25 collaborators of Georg Aue. A scholar is included among the top collaborators of Georg Aue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Georg Aue. Georg Aue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Childs, Richard, Xin Tian, Georg Aue, et al.. (2025). REMOVED: Interim Results of a Phase II Trial of Omidubicel, Ex-Vivo Expanded Umbilical Cord Blood Transplantation in Patients with Treatment-Refractory Severe Aplastic Anemia. Transplantation and Cellular Therapy. 31(2). S41–S42. 2 indexed citations
2.
Shalhoub, Ruba, Cathy Conry‐Cantilena, Susan F. Leitman, et al.. (2023). Granulocyte transfusions in severe aplastic anemia. Haematologica. 109(6). 1792–1799.
3.
Childs, Richard, Xin Tian, Enkhtsetseg Purev, et al.. (2021). Combined haploidentical and cord blood transplantation for refractory severe aplastic anaemia and hypoplastic myelodysplastic syndrome. British Journal of Haematology. 193(5). 951–960. 4 indexed citations
4.
Purev, Enkhtsetseg, Kamille A. West, Tatyana Worthy, et al.. (2020). A pilot trial of complement inhibition using eculizumab to overcome platelet transfusion refractoriness in human leukocyte antigen allo‐immunized patients. British Journal of Haematology. 189(3). 551–558. 17 indexed citations
5.
Aue, Georg, Clare Sun, Delong Liu, et al.. (2018). Activation of Th1 Immunity within the Tumor Microenvironment Is Associated with Clinical Response to Lenalidomide in Chronic Lymphocytic Leukemia. The Journal of Immunology. 201(7). 1967–1974. 21 indexed citations
6.
Allan, David, Mala Chakraborty, Emily R. Levy, et al.. (2017). High-Efficiency Lentiviral Genetic Modification of Primary Human Natural Killer Cells. Blood. 130. 5566–5566. 2 indexed citations
7.
Herndon, Thomas M., Nakhle S. Saba, Janet Valdez, et al.. (2017). Direct in vivo evidence for increased proliferation of CLL cells in lymph nodes compared to bone marrow and peripheral blood. Leukemia. 31(6). 1340–1347. 88 indexed citations
8.
9.
Mankodi, Ami, Christopher Grunseich, Lisa Cook, et al.. (2015). Divalent cation-responsive myotonia and muscle paralysis in skeletal muscle sodium channelopathy. Neuromuscular Disorders. 25(11). 908–912. 6 indexed citations
10.
Vire, Bérengère, Martin Skarzynski, Joshua D. Thomas, et al.. (2014). Harnessing the Fcμ Receptor for Potent and Selective Cytotoxic Therapy of Chronic Lymphocytic Leukemia. Cancer Research. 74(24). 7510–7520. 12 indexed citations
11.
Herman, Sarah E. M., Ellen X. Sun, Erin M. McAuley, et al.. (2013). Modeling tumor–host interactions of chronic lymphocytic leukemia in xenografted mice to study tumor biology and evaluate targeted therapy. Leukemia. 27(12). 2311–2321. 64 indexed citations
12.
Sun, Ellen X., Mark Roschewski, Georg Aue, et al.. (2012). ON 01910.Na Is Selectively Cytotoxic for Chronic Lymphocytic Leukemia Cells through a Dual Mechanism of Action Involving PI3K/AKT Inhibition and Induction of Oxidative Stress. Clinical Cancer Research. 18(7). 1979–1991. 61 indexed citations
13.
Aue, Georg, Margaret A. Lindorfer, Paul V. Beum, et al.. (2009). Fractionated subcutaneous rituximab is well-tolerated and preserves CD20 expression on tumor cells in patients with chronic lymphocytic leukemia. Haematologica. 95(2). 329–332. 42 indexed citations
14.
15.
Aue, Georg, Susan Soto, Janet Valdez, et al.. (2009). A Phase II Trial of Pulse Dosing Lenalidomide: 3 Weeks On 3 Weeks off in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.. Blood. 114(22). 3427–3427. 2 indexed citations
16.
Aue, Georg, et al.. (2008). Eine 62-jährige Frau mit progredienter Gangstörung und Panzytopenie. Der Internist. 49(12). 1512–1515. 1 indexed citations
17.
Aue, Georg, et al.. (2007). Streptococcus pneumoniae sepsis in concurrently diagnosed multiple myeloma. American Journal of Hematology. 82(9). 858–858. 4 indexed citations
18.
Aue, Georg, Nancy M. Carroll, Bruce Kressel, Robert Hardi, & McDonald K. Horne. (2005). Disseminated intravascular coagulation in an ambulatory young woman. Journal of Laboratory and Clinical Medicine. 146(3). 192–196. 3 indexed citations
19.
Aue, Georg, Bethi Muralidhar, Herbert S. Schwartz, & Merlin G. Butler. (1998). Telomerase activity in skeletal sarcomas. Annals of Surgical Oncology. 5(7). 627–634. 34 indexed citations
20.
Aue, Georg, Lora K. Hedges, Herbert S. Schwartz, et al.. (1998). Clear Cell Sarcoma or Malignant Melanoma of Soft Parts. Cancer Genetics and Cytogenetics. 105(1). 24–28. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniela Gottardi Breakdown of academic impact, for papers by Simar Pal Singh Breakdown of academic impact, for papers by Andrea G.S. Buggins Breakdown of academic impact, for papers by John H. Proffitt Breakdown of academic impact, for papers by Siddha Kasar Breakdown of academic impact, for papers by Jeffrey S. Painter Breakdown of academic impact, for papers by Sophie Gazzo Breakdown of academic impact, for papers by Stefania Fiorcari Breakdown of academic impact, for papers by Maria Ciccone Breakdown of academic impact, for papers by Bryan Ciccarelli
Rankless by CCL
2026